Abstract
The virus causes an infection that every year threatens the health of people all over the world and costs a lot of money. Even though there are now new types of viruses, antiviral drugs are still the best way to treat them. Computer-aided drug design (CADD) offers the chance to make new drugs quickly and effectively, which is different from the problems that come up in traditional research on small-molecule therapies. This chapter talks about the basics of CADD, talks about the viral proteins that are important for the virus to replicate and could be used as therapeutic targets for antiviral drugs, gives examples of how CADD has been used to screen target proteins, and talks about the general CADD procedures for both structure-based drug design and ligand-based drug design, with a focus on the strategies and targets that are commonly studied.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abiodun OI, Jantan A, Omolara AE, Dada KV, Umar AM, Linus OU, Arshad H, Kazaure AA, Gana U, Kiru MU (2019) Comprehensive review of artificial neural network applications to pattern recognition. IEEE Access 7:158820–158846. https://doi.org/10.1109/ACCESS.2019.2945545
Achary PGR (2020) Applications of quantitative structure-activity relationships (QSAR) based virtual screening in drug design: a review. Mini Rev Med Chem 20(14):1375–1388. https://doi.org/10.2174/1389557520666200429102334
Acharya C, Coop A, Polli E, MacKerell D (2011) Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des 7(1):10–22. https://doi.org/10.2174/157340911793743547
Alcami A, Lira SA (2010) Modulation of chemokine activity by viruses. Curr Opin Immunol 22(4):482–487. https://doi.org/10.1016/j.coi.2010.06.004
Anasir MI, Ramanathan B, Poh CL (2020) Structure-based design of antivirals against envelope glycoprotein of dengue virus. Viruses 12(4):367. https://doi.org/10.3390/v12040367
Anderson AC (2003) The process of structure-based drug design. Chem Biol 10(9):787–797. https://doi.org/10.1016/j.chembiol.2003.09.002
Ashraf U, Ding Z, Deng S, Ye J, Cao S, Chen Z (2021) Pathogenicity and virulence of Japanese encephalitis virus: neuroinflammation and neuronal cell damage. Virulence 12(1):968–980. https://doi.org/10.1080/21505594.2021.1899674
Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53(7):2719–2740. https://doi.org/10.1021/jm901137j
Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A, Khan Z, Sveinbjörnsson B, FuskevÅg O-M, Segerström L, Nordenskjöld M, Siesjö P, Kogner P, Johnsen JI, Söderberg-Nauclér C (2011) Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 121(10):4043–4055. https://doi.org/10.1172/JCI57147
Bassetto M, Leyssen P, Neyts J, Yerukhimovich MM, Frick DN, Brancale A (2017) Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCV. Bioorg Med Chem Lett 27(4):936–940. https://doi.org/10.1016/j.bmcl.2016.12.087
Batool M, Ahmad B, Choi S (2019) A structure-based drug discovery paradigm. Int J Mol Sci 20(11):2783. https://doi.org/10.3390/ijms20112783
Bodian DL, Yamasaki RB, Buswell RL, Stearns JF, White JM, Kuntz ID (1993) Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32(12):2967–2978. https://doi.org/10.1021/bi00063a007
Bressanelli S, Tomei L, Roussel A, Incitti I, Vitale RL, Mathieu M, De Francesco R, Rey FA (1999) Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci U S A 96(23):13034–13039. https://doi.org/10.1073/pnas.96.23.13034
Bustanji Y, Al-Masri IM, Qasem A, Al-Bakri AG, Taha MO (2009) In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation. Chem Biol Drug Des 74(3):258–265. https://doi.org/10.1111/j.1747-0285.2009.00852.x
Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75(1):50–83. https://doi.org/10.1128/MMBR.00031-10
Carpenter KA, Cohen DS, Jarrell JT, Huang X (2018) Deep learning and virtual drug screening. Future Med Chem 10(21):2557–2567. https://doi.org/10.4155/fmc-2018-0314
Carr CM, Chaudhry C, Kim PS (1997) Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A 94(26):14306–14313. https://doi.org/10.1073/pnas.94.26.14306
Chan HCS, Shan H, Dahoun T, Vogel H, Yuan S (2019) Advancing drug discovery via Artificial Intelligence. Trends Pharmacol Sci 40(10):801. https://doi.org/10.1016/j.tips.2019.07.013
Checkley MA, Luttge BG, Freed EO (2011) HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol 410(4):582–608. https://doi.org/10.1016/j.jmb.2011.04.042
Chu JJH, Yang PL (2007) c-Src protein kinase inhibitors block assembly and maturation of dengue virus. Proc Natl Acad Sci U S A 104(9):3520–3525. https://doi.org/10.1073/pnas.0611681104
Crocker TF, Brown L, Lam N, Wray F, Knapp P, Forster A (2021) Information provision for stroke survivors and their carers. Cochrane Database Syst Rev 2021(11):CD001919. https://doi.org/10.1002/14651858.CD001919.pub4
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https://doi.org/10.1038/srep42717
Di Gangi M, Lo Bosco G, Rizzo R (2018) Deep learning architectures for prediction of nucleosome positioning from sequences data. BMC Bioinformatics 19(14):418. https://doi.org/10.1186/s12859-018-2386-9
Ding L, Cao J, Lin W, Chen H, Xiong X, Ao H, Yu M, Lin J, Cui Q (2020) The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. Int J Mol Sci 21(6):1960. https://doi.org/10.3390/ijms21061960
DiPietro R, Hager GD (2020) Deep learning: RNNs and LSTM. In: Zhou SK, Rueckert D, Fichtinger G (eds) Handbook of medical image computing and computer assisted intervention, pp 503–519. Academic Press. https://doi.org/10.1016/B978-0-12-816176-0.00026-0
Emuss V, Lagos D, Pizzey A, Gratrix F, Henderson SR, Boshoff C (2009) KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathogens 5(10):e1000616. https://doi.org/10.1371/journal.ppat.1000616
Ferro S, Gitto R, Buemi MR, Karamanou S, Stevaert A, Naesens L, De Luca L (2018) Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening. Bioorg Med Chem 26(15):4544–4550. https://doi.org/10.1016/j.bmc.2018.07.046
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739–1749. https://doi.org/10.1021/jm0306430
García-Cárceles J, Caballero E, Gil C, Martínez A (2022) Kinase inhibitors as underexplored antiviral agents. J Med Chem 65(2):935–954. https://doi.org/10.1021/acs.jmedchem.1c00302
Ge Q, Huang X, Fang S, Guo S, Liu Y, Lin W, Xiong M (2020) Conditional generative adversarial networks for individualized treatment effect estimation and treatment selection. Front Genet 11:1578. https://doi.org/10.3389/fgene.2020.585804
Greene W, Kuhne K, Ye F, Chen J, Zhou F, Lei X, Gao S-J (2007) Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res 133:69–127. https://doi.org/10.1007/978-0-387-46816-7_3
Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15(7):690–698. https://doi.org/10.1038/nsmb.1456
Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE (2017) Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 16(12):829–842. https://doi.org/10.1038/nrd.2017.178
Hochreiter S (1998) The vanishing gradient problem during learning recurrent neural nets and problem solutions. Int J Uncertain Fuzz 6:107–116. https://doi.org/10.1142/S0218488598000094
Holton JM, Classen S, Frankel KA, Tainer JA (2014) The R-factor gap in macromolecular crystallography: an untapped potential for insights on accurate structures. FEBS J 281(18):4046–4060. https://doi.org/10.1111/febs.12922
Kapetanovic IM (2008) Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem Biol Interact 171(2):165–176. https://doi.org/10.1016/j.cbi.2006.12.006
Kazeminia S, Baur C, Kuijper A, van Ginneken B, Navab N, Albarqouni S, Mukhopadhyay A (2020) GANs for medical image analysis. Artif Intell Med 101938. https://doi.org/10.1016/j.artmed.2020.101938
Kosik I, Yewdell JW (2019) Influenza hemagglutinin and neuraminidase: Yin–Yang proteins coevolving to Thwart immunity. Viruses 11(4):346. https://doi.org/10.3390/v11040346
Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141(7):1117–1134. https://doi.org/10.1016/j.cell.2010.06.011
Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee J-S, Chaudhary PM, Jung J, Gill PS (2010) KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood 115(4):887–895. https://doi.org/10.1182/blood-2009-08-236745
Liu T, Zhang L, Joo D, Sun S-C (2017) NF-κB signaling in inflammation. Signal Transduct Target Ther 2(1):17023. https://doi.org/10.1038/sigtrans.2017.23
Lüttichau HR (2010) The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. J Biol Chem 285(12):9137–9146. https://doi.org/10.1074/jbc.M109.002774
Maginnis MS (2018) Virus-receptor interactions: the key to cellular invasion. J Mol Biol 430(17):2590–2611. https://doi.org/10.1016/j.jmb.2018.06.024
Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O, Michel D, van Dongen GAMS, Smit MJ (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A 103(35):13068–13073. https://doi.org/10.1073/pnas.0604433103
Mebatsion T, Weiland F, Conzelmann KK (1999) Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol 73(1):242–250. https://doi.org/10.1128/JVI.73.1.242-250.1999
Merida I, Arranz-Nicolás J, Torres-Ayuso P, Ávila-Flores A (2019) Diacylglycerol kinase malfunction in human disease and the search for specific inhibitors. In: Handbook of experimental pharmacology, vol 259, pp 133–162. https://doi.org/10.1007/164_2019_221
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785–2791. https://doi.org/10.1002/jcc.21256
Murgueitio MS, Bermudez M, Mortier J, Wolber G (2012) In silico virtual screening approaches for anti-viral drug discovery. Drug Discov Today Technol 9(3):e219–e225. https://doi.org/10.1016/j.ddtec.2012.07.009
Nissen P, Hansen J, Ban N, Moore PB, Steitz TA (2000) The structural basis of ribosome activity in peptide bond synthesis. Science (New York, N.Y.) 289(5481):920–930. https://doi.org/10.1126/science.289.5481.920
Noha SM, Jazzar B, Kuehnl S, Rollinger JM, Stuppner H, Schaible AM, Werz O, Wolber G, Schuster D (2012) Pharmacophore-based discovery of a novel cytosolic phospholipase A2α inhibitor. Bioorg Med Chem Lett 22(2):1202–1207. https://doi.org/10.1016/j.bmcl.2011.11.093
Pala N, Stevaert A, Dallocchio R, Dessì A, Rogolino D, Carcelli M, Sanna V, Sechi M, Naesens L (2015) Virtual screening and biological validation of novel influenza virus PA endonuclease inhibitors. ACS Med Chem Lett 6(8):866–871. https://doi.org/10.1021/acsmedchemlett.5b00109
Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191(3):573–578. https://doi.org/10.1084/jem.191.3.573
Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK (2021) Artificial intelligence in drug discovery and development. Drug Discov Today 26(1):80–93. https://doi.org/10.1016/j.drudis.2020.10.010
Pillaiyar T, Laufer S (2022) Kinases as potential therapeutic targets for anti-coronaviral therapy. J Med Chem. 65(2):955–982. https://doi.org/10.1021/acs.jmedchem.1c00335
Ploubidou A, Way M (2001) Viral transport and the cytoskeleton. Curr Opin Cell Biol 13(1):97–105. https://doi.org/10.1016/s0955-0674(00)00180-0
Pontejo SM, Murphy PM (2017) Chemokines encoded by herpesviruses. J Leukoc Biol. 102(5):1199–1217. https://doi.org/10.1189/jlb.4RU0417-145RR
Rajamaki S, Innitzer A, Falciani C, Tintori C, Christ F, Witvrouw M, Debyser Z, Massa S, Botta M (2009) Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors. Bioorg Med Chem Lett 19(13):3615–3618. https://doi.org/10.1016/j.bmcl.2009.04.132
Roychoudhury S, Das A, Sengupta P, Dutta S, Roychoudhury S, Choudhury AP, Ahmed ABF, Bhattacharjee S, Slama P (2020) Viral pandemics of the last four decades: pathophysiology, health impacts and perspectives. Int J Environ Res Public Health 17(24):9411. https://doi.org/10.3390/ijerph17249411
Ryu K, Kim ND, Il CS, Han CK, Yoon JH, No KT, Kim K-H, Seong BL (2009) Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation. Bioorg Med Chem 17(8):2975–2982. https://doi.org/10.1016/j.bmc.2009.03.024
Ryzhova EV, Vos RM, Albright AV, Harrist AV, Harvey T, González-Scarano F (2006) Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages. J Virol 80(6):2694–2704. https://doi.org/10.1128/JVI.80.6.2694-2704.2006
Schuster D, Kowalik D, Kirchmair J, Laggner C, Markt P, Aebischer-Gumy C, Ströhle F, Möller G, Wolber G, Wilckens T, Langer T, Odermatt A, Adamski J (2011a) Identification of chemically diverse, novel inhibitors of 17β-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screening. J Steroid Biochem Mol Biol 125(1–2):148–161. https://doi.org/10.1016/j.jsbmb.2011.01.016
Schuster D, Markt P, Grienke U, Mihaly-Bison J, Binder M, Noha SM, Rollinger JM, Stuppner H, Bochkov VN, Wolber G (2011b) Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation. Bioorg Med Chem 19(23):7168–7180. https://doi.org/10.1016/j.bmc.2011.09.056
Sen B, Johnson FM (2011) Regulation of SRC family kinases in human cancers. J Signal Transduct 2011:865819. https://doi.org/10.1155/2011/865819
Shahid N, Rappon T, Berta W (2019) Applications of artificial neural networks in health care organizational decision-making: a scoping review. PloS One 14(2):e0212356–e0212356. https://doi.org/10.1371/journal.pone.0212356
Sharma P, Sethi G, Tripathi MK, Rana S, Singh H, Kaur P (2023) Role of nature-inspired intelligence in genomic diagnosis of antimicrobial resistance BT. In: Raza K (ed) Nature-inspired intelligent computing techniques in bioinformatics. Springer Nature, Singapore, pp 223–245. https://doi.org/10.1007/978-981-19-6379-7_12
Shrivastava R, Yasir M, Tripathi M, Singh P (2016) In silico interaction of methyl isocyanate with immune protein responsible for Mycobacterium tuberculosis infection using molecular docking. Toxicol Ind Health 32(1):162–167. https://doi.org/10.1177/0748233713498447
Simidjievski N, Bodnar C, Tariq I, Scherer P, Andres Terre H, Shams Z, Jamnik M, Liò P (2019) Variational autoencoders for cancer data integration: design principles and computational practice. Front Genet 10(1205). https://doi.org/10.3389/fgene.2019.01205
Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev 66(1):334–395. https://doi.org/10.1124/pr.112.007336
Sohraby F, Bagheri M, Aryapour H (2019) Performing an in silico repurposing of existing drugs by combining virtual screening and molecular dynamics simulation. In: Clifton NJ (ed) Methods in molecular biology, vol 1903, pp 23–43. https://doi.org/10.1007/978-1-4939-8955-3_2
Sorrell FJ, Szklarz M, Abdul Azeez KR, Elkins JM, Knapp S (2016) Family-wide structural analysis of human numb-associated protein kinases. Structure 24(3):401–411. https://doi.org/10.1016/j.str.2015.12.015
SYSTÈMES D (2016) BIOVIA discovery studio. In Dassault Syst mes BIOVIA, Discovery Studio Modeling Environment, Release 2017 Dassault Syst mes. http://accelrys.com/products/collaborative-science/biovia-discovery-studio/
Takaya D, Yamashita A, Kamijo K, Gomi J, Ito M, Maekawa S, Enomoto N, Sakamoto N, Watanabe Y, Arai R, Umeyama H, Honma T, Matsumoto T, Yokoyama S (2011) A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors. Bioorg Med Chem 19(22):6892–6905. https://doi.org/10.1016/j.bmc.2011.09.023
Tang B, Pan Z, Yin K, Khateeb A (2019) Recent advances of deep learning in bioinformatics and computational biology. Front Genet 10(214). https://doi.org/10.3389/fgene.2019.00214
Tripathi MK, Yasir M, Gurjar VS, Bose P, Dubey A, Shrivastava R (2015) Insights from the molecular docking of hydrolytic products of methyl isocyanate (MIC) to inhibition of human immune proteins. Interdiscip Sci 7(3):287–294. https://doi.org/10.1007/s12539-015-0012-3
Tripathi MK, Yasir M, Singh P, Tayubi IA, Gupta R, Shrivastava R (2016) Toxic effect of chemicals dumped in premises of UCIL, Bhopal leading to environmental pollution: an in silico approach. Asian Pac J Trop Dis 6(4):284–290. https://doi.org/10.1016/S2222-1808(15)61032-5
Tripathi MK, Sinha J, Srivastava SK, Kumar D (2019) Bioinformatics in skin cancer: a system biology approach to understanding the molecular mechanisms and it’s regulations BT - skin aging & cancer: ambient UV-R exposure (A Dwivedi, N Agarwal, L Ray, AK Tripathi, eds). Springer, Singapore, pp 101–111. https://doi.org/10.1007/978-981-13-2541-0_10
Tripathi MK, Nath A, Singh TP, Ethayathulla AS, Kaur P (2021a) Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. Mol Divers 25(3):1439–1460. https://doi.org/10.1007/s11030-021-10256-w
Tripathi MK, Sharma S, Singh TP, Ethayathulla AS, Kaur P (2021b) Computational intelligence in drug repurposing for COVID-19 BT - computational intelligence methods in COVID-19: surveillance, prevention, prediction and diagnosis (K Raza, ed). Springer, Singapore, pp 273–294. https://doi.org/10.1007/978-981-15-8534-0_14
Tripathi MK, Ahmad S, Tyagi R, Dahiya V, Yadav MK (2022) Fundamentals of molecular modeling in drug design. In: Rudrapal M, CBT-CADD (CADD): FL-BM to S-BA Egbuna (eds) Drug discovery update. Elsevier, pp 125–155. https://doi.org/10.1016/B978-0-323-90608-1.00001-0
Trott O, Olson AJ (2009) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2). https://doi.org/10.1002/jcc.21334
Vilar S, Cozza G, Moro S (2008) Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 8(18):1555–1572. https://doi.org/10.2174/156802608786786624
Waldmann M, Jirmann R, Hoelscher K, Wienke M, Niemeyer FC, Rehders D, Meyer B (2014) A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza. J Am Chem Soc 136(2):783–788. https://doi.org/10.1021/ja410918a
Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45(1):160–169. https://doi.org/10.1021/ci049885e
Wolber G, Dornhofer AA, Langer T (2007) Efficient overlay of small organic molecules using 3D pharmacophores. J Comput Aided Mol Des 20(12):773–788. https://doi.org/10.1007/s10822-006-9078-7
Wu Y, Wei F, Tang L, Liao Q, Wang H, Shi L, Gong Z, Zhang W, Zhou M, Xiang B, Wu X, Li X, Li Y, Li G, Xiong W, Zeng Z, Xiong F, Guo C (2019) Herpesvirus acts with the cytoskeleton and promotes cancer progression. J Cancer 10(10):2185–2193. https://doi.org/10.7150/jca.30222
Yang Y, Zhu Z, Wang X, Zhang X, Mu K, Shi Y, Peng C, Xu Z, Zhu W (2021) Ligand-based approach for predicting drug targets and for virtual screening against COVID-19. Brief Bioinform 22(2):1053–1064. https://doi.org/10.1093/bib/bbaa422
Yángüez E, Hunziker A, Dobay MP, Yildiz S, Schading S, Elshina E, Karakus U, Gehrig P, Grossmann J, Dijkman R, Schmolke M, Stertz S (2018) Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun 9(1):3679. https://doi.org/10.1038/s41467-018-06119-y
Yin H, Jiang N, Shi W, Chi X, Liu S, Chen J-L, Wang S (2021) Development and effects of influenza antiviral drugs. Molecules 26(4):810. https://doi.org/10.3390/molecules26040810
Zhang J, Wang Y (2021) Bilobetin, a novel small molecule inhibitor targeting influenza virus polymerase acidic (PA) endonuclease was screened from plant extracts. Nat Prod Res 35(24):5968–5971. https://doi.org/10.1080/14786419.2020.1808636
Zhang C, Xiang J, Xie Q, Zhao J, Zhang H, Huang E, Shaw P, Liu X, Hu C (2021a) Identification of influenza PAN endonuclease inhibitors via 3D-QSAR modeling and docking-based virtual screening. Molecules 26(23):7129. https://doi.org/10.3390/molecules26237129
Zhang M, Zhang L, Hei R, Li X, Cai H, Wu X, Zheng Q, Cai C (2021b) CDK inhibitors in cancer therapy, an overview of recent development. Am J Cancer Res 11(5):1913–1935
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yasir, M., Tripathi, A.S., Tripathi, M.K., Shukla, P., Maurya, R.K. (2023). CADD Approaches and Antiviral Drug Discovery. In: Rudrapal, M., Khan, J. (eds) CADD and Informatics in Drug Discovery. Interdisciplinary Biotechnological Advances. Springer, Singapore. https://doi.org/10.1007/978-981-99-1316-9_13
Download citation
DOI: https://doi.org/10.1007/978-981-99-1316-9_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1315-2
Online ISBN: 978-981-99-1316-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)